Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APICALE: Dexamethasone for Cervicobrachial Neuralgia
NCT07084285Phase 3Not yet recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2026
- Primary completion
- Feb 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in cervicobrachial neuralgia, sponsored by Assistance publique - Hôpitaux de Paris. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
cervicobrachial neuralgia
Beyond the preview
Go deeper on NCT07084285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07084285.